The estimated Net Worth of Elizabeth E Tallett is at least $2.38 Milione dollars as of 28 April 2022. Ms. Tallett owns over 703 units of Anthem Inc stock worth over $339,254 and over the last 16 years she sold ANTM stock worth over $1,480,632. In addition, she makes $564,395 as Independent Chairman of the Board at Anthem Inc.
Sign up
Ms. Tallett ANTM stock SEC Form 4 insiders trading
Elizabeth has made over 15 trades of the Anthem Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently she exercised 703 units of ANTM stock worth $339,254 on 28 April 2022.
The largest trade she's ever made was selling 22,800 units of Anthem Inc stock on 20 May 2021 worth over $1,480,632. On average, Elizabeth trades about 212 units every 14 days since 2008. As of 28 April 2022 she still owns at least 703 units of Anthem Inc stock.
You can see the complete history of Ms. Tallett stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Elizabeth Tallett biography
Elizabeth E. Tallett is Independent Chairman of the Board of Anthem, Inc., effective May 16, 2018. She was a principal of Hunter Partners, LLC (healthcare consulting) from 2002 to 2015. Ms. Tallett continues to operate as a consultant to healthcare companies. Previously, Ms. Tallett was President and Chief Executive Officer of Transcell Technologies, Inc. (specialty pharmaceuticals), President of Centocor Pharmaceuticals (biotechnology), member of the Parke-Davis (pharmaceuticals) Executive Committee and Director of Worldwide Strategic Planning for Warner-Lambert Company (pharmaceuticals). Ms. Tallett has served as a director of Meredith Corporation (magazine publisher) since 2008, Principal Financial Group, Inc. (financial services) since 1992 (as lead director from 2007 until December 2019) and Qiagen, N.V. (biotechnology research equipment manufacturing) since 2011. She previously served as a director of Coventry Health Care, Inc. (health insurance) from 1998 to 2013 (including serving as lead director).
What is the salary of Elizabeth Tallett?
As the Independent Chairman of the Board of Anthem Inc, the total compensation of Elizabeth Tallett at Anthem Inc is $564,395. There are 11 executives at Anthem Inc getting paid more, with Gail Boudreaux having the highest compensation of $15,473,100.
How old is Elizabeth Tallett?
Elizabeth Tallett is 71, she's been the Independent Chairman of the Board of Anthem Inc since 2018. There are 1 older and 23 younger executives at Anthem Inc. The oldest executive at Anthem Inc is Julie Hill, 73, who is the Independent Director.
What's Elizabeth Tallett's mailing address?
Elizabeth's mailing address filed with the SEC is C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE, MA, 02142.
Insiders trading at Anthem Inc
Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider e Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.
What does Anthem Inc do?
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
What does Anthem Inc's logo look like?
Complete history of Ms. Tallett stock trades at Anthem Inc, Meredith Corp, Principal Inc, Principal Inc e Moderna Inc
Anthem Inc executives and stock owners
Anthem Inc executives and other stock owners filed with the SEC include:
-
Gail Boudreaux,
President, Chief Executive Officer, Director -
Felicia Norwood,
Executive Vice President, President - Government Business Division -
Gloria McCarthy,
Executive Vice President, Chief Administrative Officer -
Gail Koziara Boudreaux,
Pres, CEO & Director -
John Gallina,
Chief Financial Officer, Executive Vice President -
Peter Haytaian,
Executive Vice President, President of Commercial and Specialty Business Division -
Thomas Zielinski,
Executive Vice President, General Counsel -
John Edward Gallina,
Exec. VP & CFO -
Gloria Marie McCarthy,
Exec. VP and Chief Admin. Officer -
Peter David Haytaian Esq.,
Exec. VP and Pres of Diversified Bus. & IngenioRx -
Felicia Farr Norwood,
Exec. VP & Pres of Gov. Bus. Division -
Elizabeth Tallett,
Independent Chairman of the Board -
Ramiro Peru,
Independent Director -
Julie Hill,
Independent Director -
Robert Dixon,
Independent Director -
Lewis Hay,
Independent Director -
R. Kerry Clark,
Independent Director -
Antonio Neri,
Independent Director -
Bahija Jallal,
Independent Director -
Ryan Schneider,
Independent Director -
Chris Rigg,
Vice President Investor Relations -
Ronald Penczek,
Senior Vice President, Chief Accounting Officer, Controller -
Prakash Patel,
Executive Vice President, President - Diversified Business Group -
Leah Stark,
Chief Human Resource Officer, Executive Vice President -
Stephen Vartan Tanal C.F.A.,
VP of Investor Relations -
Thomas H. Miller,
Sr. VP & Chief Information Officer -
Anil Bhatt,
Chief Technology Officer -
Ronald William Penczek,
Sr. VP, Controller & Chief Accounting Officer -
Scott Wayne Anglin,
SVP, Treasurer & Chief Investment Officer -
Joseph Swedish,
President & CEO -
William J Ryan,
Director -
George A Jr Schaefer,
Director -
Jose D. Tomas,
EVP & Chief HR Officer -
Jacquelyn H Wolf,
EVP & Chief HR Officer -
Craig E Samitt,
EVP & Chief Clinical Officer -
Wayne S De Veydt,
EVP & Chief Financial Officer -
Brian T Griffin,
EVP & President, CSBD -
Samuel R Md Nussbaum,
EVP & Chief Medical Officer -
Martin B Silverstein,
EVP & Chief Strategy Officer -
Kenneth R Goulet,
EVP, Commercial & Specialty -
Blair Williams Todt,
EVP and Chief Legal Officer -
Jeffrey D. Alter,
EVP, IngenioRx & Anthem Health -
Susan D. De Vore,
Director -
Charles Morgan Jr Kendrick,
EVP & President, Commercial